chr17-31232129-T-G
Variant summary
Our verdict is Likely pathogenic. Variant got 8 ACMG points: 8P and 0B. PM1PM2PP2PP3_ModeratePP5
The ENST00000358273.9(NF1):c.3254T>G(p.Leu1085Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. L1085V) has been classified as Likely benign.
Frequency
Consequence
ENST00000358273.9 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NF1 | NM_001042492.3 | c.3254T>G | p.Leu1085Arg | missense_variant | 25/58 | ENST00000358273.9 | NP_001035957.1 | |
NF1 | NM_000267.3 | c.3254T>G | p.Leu1085Arg | missense_variant | 25/57 | NP_000258.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NF1 | ENST00000358273.9 | c.3254T>G | p.Leu1085Arg | missense_variant | 25/58 | 1 | NM_001042492.3 | ENSP00000351015 | P1 |
Frequencies
GnomAD3 genomes Cov.: 29
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 29
ClinVar
Submissions by phenotype
Hereditary cancer-predisposing syndrome;CN230736:Cardiovascular phenotype Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 06, 2023 | The p.L1085R variant (also known as c.3254T>G), located in coding exon 25 of the NF1 gene, results from a T to G substitution at nucleotide position 3254. The leucine at codon 1085 is replaced by arginine, an amino acid with dissimilar properties. This variant has been detected in multiple unrelated individuals with a clinical diagnosis of neurofibromatosis type 1 (Ambry internal data). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. This variant is considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). Based on the majority of available evidence to date, this variant is likely to be pathogenic. - |
Inborn genetic diseases Uncertain:1
Uncertain significance, flagged submission | clinical testing | Ambry Genetics | Jun 22, 2015 | - - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Dec 03, 2020 | The NF1 c.3254T>G; p.Leu1085Arg variant (rs1555614849), to our knowledge, is not reported in the medical literature but is reported in ClinVar (Variation ID: 520698). This variant is absent from general population databases (Exome Variant Server, Genome Aggregation Database), indicating it is not a common polymorphism. The leucine at codon 1085 is highly conserved, and computational analyses predict that this variant is deleterious (REVEL: 0.74). Due to limited information, the clinical significance of the p.Leu1085Arg variant is uncertain at this time. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at